skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Lessons from International Experience with Biosimilar Implementation: An Application of the Diffusion of Innovations Model

Healthcare policy, 2020-02, Vol.15 (3), p.16-27 [Peer Reviewed Journal]

Copyright © 2020 Longwoods Publishing ;Copyright Longwoods Publishing Corporation Feb 2020 ;Copyright © 2020 Longwoods Publishing 2020 Longwoods Publishing ;ISSN: 1715-6572 ;EISSN: 1715-6580 ;DOI: 10.12927/hcpol.2020.26133 ;PMID: 32176608

Full text available

Citations Cited by
  • Title:
    Lessons from International Experience with Biosimilar Implementation: An Application of the Diffusion of Innovations Model
  • Author: Khan, Danial ; Luig, Thea ; Mosher, Dianne ; Campbell-Scherer, Denise
  • Subjects: Biological products ; Cost control ; Decision making ; Discussion and Debate ; Health care expenditures ; Implementation ; Innovations ; Meaning ; Savings ; Uptake
  • Is Part Of: Healthcare policy, 2020-02, Vol.15 (3), p.16-27
  • Description: Although biosimilars offer cost savings in Canadian healthcare, uptake is low. We discuss the literature on international experiences with biosimilar adoption in the context of the Diffusion of Innovations model. We highlight potential challenges with biosimilar implementation and gaps in research needed to inform implementation efforts. We observe a lack of systematic description of implementation design and evaluation and a paucity of in-depth and engaged research to understand stakeholders' pragmatic considerations and the knowledge, messages and meanings that shape clinician and patient decisions to choose biosimilars.
  • Publisher: Toronto: Longwoods Publishing
  • Language: English;French
  • Identifier: ISSN: 1715-6572
    EISSN: 1715-6580
    DOI: 10.12927/hcpol.2020.26133
    PMID: 32176608
  • Source: PubMed Central

Searching Remote Databases, Please Wait